Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Echo Therapeutics Inc    

SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Echo Therapeutics, Inc. (OTCMKTS:ECTE) Files An 8-K Other Events

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/28/2016 | 03:39pm CET

Echo Therapeutics, Inc. (OTCMKTS:ECTE) Files An 8-K Other EventsItem 8.01 Other Events.

On December 21, 2016, Echo Therapeutics, Inc. issued a press release, a copy of which is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1
Press Release, dated December 21, 2016.
About Echo Therapeutics, Inc. (OTCMKTS:ECTE)
Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States. Echo Therapeutics, Inc. (OTCMKTS:ECTE) Recent Trading Information
Echo Therapeutics, Inc. (OTCMKTS:ECTE) closed its last trading session 00.000 at 0.214 with 313,339 shares trading hands.

The post Echo Therapeutics, Inc. (OTCMKTS:ECTE) Files An 8-K Other Events appeared first on Market Exclusive.

© Market Exclusive 2016, source Market Exclusive

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ECHO THERAPEUTICS INC
2016 ECHO THERAPEUTICS, INC. (OTCMKTS : ECTE) Files An 8-K Other Events
2016 ECHO THERAPEUTICS, INC. (NASDAQ : ECTE) Files An 8-K Other Events
2016 MANCHESTER MANAGEMENT LLC REPORTS : New York Federal Court Grants Temporary Rest..
2016 ECHO THERAPEUTICS, INC. (OTCMKTS : ECTE) Files An 8-K Other Events
2016 ECHO THERAPEUTICS, INC. (OTCMKTS : ECTE) Files An 8-K Other Events
2016 ECHO THERAPEUTICS, INC. (OTCMKTS : ECTE) Files An 8-K Entry into a Material Defi..
2016 Delisting of Securities of BIND Therapeutics, Inc., InterCloud Systems, Inc.,..
2016 ECHO THERAPEUTICS : Announces Second Quarter 2016 Financial Results
2016 ECHO THERAPEUTICS : Announces Second Quarter 2016 Financial Results
2016 OTC MARKETS : Welcomes Newly Verified OTCQB Companies
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
2016 EXCLUSIVE : U.S. regulator poised to approve Abbott purchase of St Jude - source..
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
2016 District court rules in favor of Echo Therapeutics
2016 Echo Therapeutics target of whistleblower suit, survival at stake; shares dow..
2016 Echo Therapeutics auditor quits; shares down 14%
2016 Echo Therapeutics reports Q2 results
2016 Midday Gainers /Losers
Advertisement
Chart ECHO THERAPEUTICS INC
Duration : Period :
Echo Therapeutics Inc Technical Analysis Chart | US27876L2060 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Alan Wayne Schoenbart Chief Executive Officer, CFO & Secretary
Mike M. Goldberg Chairman
Thomas H. Bishop Vice President-Operations & Product Development
Shepard M. Goldberg Independent Director
Christine H. Olimpio Director-Investor Relations & Communications
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ECHO THERAPEUTICS INC-16.20%2
THERMO FISHER SCIENTIF..2.80%57 298
DANAHER CORPORATION3.94%55 966
BOSTON SCIENTIFIC CORP..10.49%32 544
PHILIPS-2.64%28 034
INTUITIVE SURGICAL, IN..4.66%25 718
More Results